← Back to Vital Edge Science
← Back to Vital Edge Science Compound Comparison Tool

How are these compounds
scientifically different?

Compare mechanisms, targets, research profiles and pharmacokinetics for up to 4 compounds side by side. This maps what is scientifically known — it does not tell you which compound to choose.

This is a scientific comparison, not a recommendation. It does not answer "which should I take?" — for potential combination-specific considerations, see the Interaction Checker; for regulatory/clinical-development history, see the Research Status Explorer.

Kisspeptin-10 × HCG × 2 of 4 selected View comparison

Kisspeptin-10

Kisspeptin fragment

Remove
VS

HCG

Glycoprotein hormone

Remove

Target & Mechanism Comparison

Primary molecular targets for each selected compound, drawn directly from each compound's structured scientific record. Not every compound has a single conventional receptor target — where that's the case, its differentiating mechanism is noted below instead.

← Scroll to see all compounds →

Target Kisspeptin-10HCG
✓ —
— ✓

Pathway Map

This is a schematic, not a claim that every step shown has been directly demonstrated for each compound. The receptor immediately after each compound is its direct, structurally-confirmed target; anything shown beyond that receptor represents the broader documented signalling axis for that receptor family in general, not a compound-specific downstream finding.

Kisspeptin-10 → KISS1R (direct target) → GnRH → Pituitary → LH / FSH → Gonads Steps after KISS1R are the established downstream reproductive axis, not a Kisspeptin-10-specific measurement.
HCG → LHCGR (direct target) → Gonads

What These Compounds Share

Shared pathway tags
Reproductive Axis
Shared research areas
Reproductive endocrinologyFertility research

Key Differences

Kisspeptin-10 KISS1R is a direct target of Kisspeptin-10 that none of the other selected compounds share. Acts upstream within the reproductive endocrine axis compared with HCG's direct LHCGR activity.
HCG LHCGR is a direct target of HCG that none of the other selected compounds share. Acts directly at LH/CG receptors rather than upstream hypothalamic kisspeptin/GnRH signalling.

Compound Detail

Kisspeptin-10
What is it?
A fragment of a natural hormone that kick-starts the body's reproductive hormone signal chain.
What are people researching/using it for?
Studied for reproductive hormone and fertility research.
Other uses being trialed
General hypothalamic-pituitary-gonadal axis research
Worth knowing
Very short reported IV half-life limits direct comparison with longer-acting reproductive-axis compounds. The source study used small groups (4-5 participants per arm) -- a real human PK measurement, but not a large-sample study.

Simplified for general understanding. Switch to "Full science" above for the complete research-level detail, targets, pharmacokinetics and sources.

Identity
What is it?
Acts upstream within the reproductive endocrine axis, stimulating GnRH-neuron signalling.
Decapeptide · 10 amino acids · Fragment of endogenous kisspeptin
Also known as: KP-10
Primary Targets & Biological System
Hypothalamic-pituitary-gonadal axis

Tap a target above for a plain-language explanation.

Mechanism & Research Profile
How does it work?
A fragment of the kisspeptin peptide that activates KISS1R, a receptor found on GnRH-producing neurons in the hypothalamus. This is the first step in the reproductive hormone cascade: KISS1R activation stimulates GnRH release, which signals the pituitary to release LH and FSH, which in turn act on the gonads. This upstream position in the hypothalamic-pituitary-gonadal axis is the key mechanistic distinction from HCG, which instead acts directly on the gonads' LH/CG receptor and bypasses this entire upstream signalling chain.
Research Areas
Reproductive endocrinologyGnRH signallingLH/FSH physiologyFertility researchHypothalamic reproductive signalling
Research Profile
Human administration: Available Preclinical: Available
Pharmacokinetics
Approximately 3.8-4.1 minutes (IV bolus)
Measured directly in a human IV-bolus PK study (small groups of 4-5 participants each for men, follicular-phase women, and preovulatory women -- no significant difference between groups).
Research Routes
Intravenous (research contexts) (descriptive only — not administration or dosing guidance)
Key Differentiator
Acts upstream within the reproductive endocrine axis compared with HCG's direct LHCGR activity.
Considerations
Research Limitations
Very short reported IV half-life limits direct comparison with longer-acting reproductive-axis compounds. The source study used small groups (4-5 participants per arm) -- a real human PK measurement, but not a large-sample study.
Experimental / Off-Label Research

Not an approved or established use. These are active or emerging research directions found in the literature, shown for informational context only — not a claim that this compound is approved, effective, or safe for these purposes.

IVF outcome research
Kisspeptin has been investigated as a trigger for egg maturation in IVF protocols, as an alternative to hCG-based triggers, on the basis of its upstream role in the reproductive axis. An active clinical research area, not yet a standard-of-care alternative.
Hypothalamic amenorrhea
Researched for restoring reproductive hormone signalling in women with hypothalamic amenorrhea (absent periods due to disrupted GnRH signalling), given kisspeptin's role as the upstream trigger for that pathway.
Availability & Sources
Current Vital Edge Testing
No current batch testing on file yet.
Available As (Vital Edge Science)
Kisspeptin-10 · A$74.95 A$84.95
Browse products →
View Research Sources (1) →
Effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans
Journal of Clinical Endocrinology & Metabolism, 2011 · Human Human · Small groups (4-5 participants each) of men, follicular-phase women, and preovulatory-phase women · Intravenous bolus (SC bolus and IV infusion also used in women) · PMID 21976724

Plasma half-life 3.8±0.3 min (men), 4.1±0.4 min (follicular women), 4.1±0.4 min (preovulatory women) -- no significant difference between groups (P=0.91). Confirmed direct LH/FSH stimulation via KISS1R, with a sexually-dimorphic response depending on cycle phase.

Supports: human_half_life, mechanism_summary

HCG
What is it?
A natural pregnancy-related hormone that also signals the ovaries or testes directly.
What are people researching/using it for?
Long used in fertility research and to support reproductive hormone function.
Other uses being trialed
Testosterone support research in menOvulation-related research
Worth knowing
A large glycoprotein hormone, not a short synthetic peptide -- should not be treated as pharmacokinetically comparable to the catalogue's smaller peptides. Reported clearance also varies by population and route -- the figure shown was measured specifically in pituitary-suppressed women, not a general/mixed population.

Simplified for general understanding. Switch to "Full science" above for the complete research-level detail, targets, pharmacokinetics and sources.

Identity
What is it?
Activates LH/CG receptors and downstream gonadal steroidogenic signalling.
Heterodimeric glycoprotein hormone · Endogenous hormone
Primary Targets & Biological System
Reproductive / endocrine axis

Tap a target above for a plain-language explanation.

Mechanism & Research Profile
How does it work?
Activates the LH/CG receptor (LHCGR) on cells in the gonads, mimicking luteinizing hormone. This directly stimulates steroidogenesis -- production of sex hormones -- in the testes or ovaries, without requiring the upstream hypothalamic/pituitary signalling (GnRH, then LH) that normally triggers this receptor. This is the key mechanistic distinction from kisspeptin-based compounds, which act far upstream of the gonads and depend on an intact hypothalamic-pituitary axis to have any downstream effect.
Research Areas
Reproductive endocrinologyGonadal functionFertility researchSteroidogenesisReproductive physiology
Research Profile
Human administration: Extensive Preclinical: Available
Pharmacokinetics
Approximately 32-33 hours
Reported in a randomized three-way crossover study of pituitary-suppressed women (IM vs. SC dosing) -- Tmax ~20h across all arms, elimination half-life ~32-33h regardless of route/dose. This population (pituitary-down-regulated women) is not the same as the healthy-men study also on file for this compound; the two should not be conflated.
Research Routes
Subcutaneous, Intramuscular (descriptive only — not administration or dosing guidance)
Key Differentiator
Acts directly at LH/CG receptors rather than upstream hypothalamic kisspeptin/GnRH signalling.
Considerations
Research Limitations
A large glycoprotein hormone, not a short synthetic peptide -- should not be treated as pharmacokinetically comparable to the catalogue's smaller peptides. Reported clearance also varies by population and route -- the figure shown was measured specifically in pituitary-suppressed women, not a general/mixed population.
Experimental / Off-Label Research

Not an approved or established use. These are active or emerging research directions found in the literature, shown for informational context only — not a claim that this compound is approved, effective, or safe for these purposes.

"HCG diet" for weight loss
Widely marketed since the 1950s as a weight-loss aid alongside very-low-calorie diets. The FDA has explicitly stated this use is not supported by credible evidence and that over-the-counter HCG products marketed for weight loss are illegal to sell in the US. Included here as a caution, not a legitimate experimental research direction.
Availability & Sources
Current Vital Edge Testing
No current batch testing on file yet.
Available As (Vital Edge Science)
HCG · A$69.95 A$89.95
Browse products →
View Research Sources (2) →
Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotropin
Fertility and Sterility, 1991 · Human Human · 24 healthy men, mean age 22.7±4.3 years · Subcutaneous vs Intramuscular · PMID 1712735 · DOI 10.1016/S0015-0282(16)54476-8

Peak concentration significantly delayed and half-life prolonged after SC vs IM (both P=0.01); testosterone/LH/FSH responses were equivalent between routes.

Supports: human_half_life

A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration
Human Reproduction, 1998 · Human Human · 18 healthy, pituitary-suppressed (down-regulated) WOMEN -- not men, and not a general population · Intramuscular (5,000 & 10,000 IU) vs Subcutaneous (10,000 IU), randomized 3-way crossover · PMID 9688371

Tmax ~20h and elimination half-life ~32-33h across all three arms, regardless of route/dose. Concludes SC is bioequivalent to IM. This population (pituitary-suppressed women) is distinct from the healthy-men study above -- do not treat the two as interchangeable populations.

Supports: human_half_life

Common Research Comparisons

Frequently studied groupings — not recommendations.

Browse more compounds

Metabolic

5-Amino-1MQ

NNMT inhibitor

NNMTNicotinamideNAD MetabolismSmall Molecule
Rebuild

BPC-157

Gastric pentadecapeptide

GI ResearchTissue RepairAngiogenesisNO-associated
Metabolic

Cagrilintide

Long-acting amylin analogue

AmylinSatietyAppetiteMetabolic
Peak

CJC-1295

Modified GHRH analogue

GHRHRModified GRFGHIGF-1
Neuro

DSIP

Neuropeptide

Sleep ResearchNeuropeptideNeuroendocrineCNS
Rebuild

Epithalon

Synthetic tetrapeptide

Telomere ResearchTelomeraseCellular AgeingTetrapeptide
Rebuild

GHK-Cu

Copper-binding tripeptide

Copper PeptideECMFibroblastCollagen
Peak

GHRP-2

GH-releasing peptide / GH secretagogue

GHSR1aGhrelinGH SecretagogueAppetite
Rebuild

Glutathione

Endogenous antioxidant tripeptide

GSHRedoxAntioxidantOxidative Stress
Metabolic

HCG

Glycoprotein hormone

LHCGRReproductive AxisGonadalEndocrine
Reference

IGF-1 LR3

IGF-1 receptor agonist (engineered analogue)

IGF1RGrowth FactorPI3K/AKTRAS/MAPK
Peak

Ipamorelin

GH secretagogue

GHSR1aGH SecretagogueGhrelin PathwayGH
Enhance

Kisspeptin-10

Kisspeptin fragment

KISS1RGnRHLHFSH
Rebuild

KPV

α-MSH-derived tripeptide

KPVα-MSH FragmentInflammationIL-1-associated
Enhance

Melanotan I

α-MSH analogue

MC1RMelanocortinPigmentationα-MSH Analogue
Enhance

Melanotan II

Cyclic melanocortin agonist

MelanocortinMC ReceptorsPigmentationCyclic Peptide
Metabolic

MOTS-c

Mitochondrial-derived peptide

MitochondrialAMPK-associatedMetabolicExercise Biology
Metabolic

NAD+

Cellular redox cofactor

NAD+RedoxCellular EnergySirtuins
Enhance

PT-141

Cyclic melanocortin receptor agonist

MelanocortinMC4R-associatedCNSSexual Response
Metabolic

Retatrutide

Triple receptor agonist

GLP-1RGIPRGCGRIncretin
Reference

rHGH (Somatropin)

Growth hormone receptor agonist

GHRIGF-1Growth HormonePituitary-independent
Neuro

Selank

Synthetic tuftsin analogue

Tuftsin AnalogueCNSStress ResearchNeurotransmitter Research
Metabolic

Semaglutide

GLP-1 receptor agonist

GLP-1RIncretinMetabolicGlucose
Neuro

Semax

Synthetic ACTH-fragment analogue

ACTH FragmentNeurotrophinBDNF-associatedCNS
Peak

Sermorelin

GHRH fragment analogue

GHRHRGHRH(1-29)PituitaryGH
Rebuild

SS-31

Mitochondria-targeting tetrapeptide

MitochondriaCardiolipinInner Mitochondrial MembraneBioenergetics
Peak

Tesamorelin

Stabilised GHRH analogue

GHRHRGHIGF-1Pituitary
Rebuild

Thymosin Alpha-1

Thymic peptide

ImmuneT CellsTLR-associatedInnate Immunity
Rebuild

Thymosin Beta-4 (TB-4)

Thymosin Beta-4

Thymosin Beta-4Actin BiologyCell MigrationRepair Research
Metabolic

Tirzepatide

Dual incretin receptor agonist

GIPRGLP-1RDual AgonistIncretin

Choose a compound

Metabolic

5-Amino-1MQ

NNMT inhibitor

NNMTNicotinamideNAD MetabolismSmall Molecule
Rebuild

BPC-157

Gastric pentadecapeptide

GI ResearchTissue RepairAngiogenesisNO-associated
Metabolic

Cagrilintide

Long-acting amylin analogue

AmylinSatietyAppetiteMetabolic
Peak

CJC-1295

Modified GHRH analogue

GHRHRModified GRFGHIGF-1
Neuro

DSIP

Neuropeptide

Sleep ResearchNeuropeptideNeuroendocrineCNS
Rebuild

Epithalon

Synthetic tetrapeptide

Telomere ResearchTelomeraseCellular AgeingTetrapeptide
Rebuild

GHK-Cu

Copper-binding tripeptide

Copper PeptideECMFibroblastCollagen
Peak

GHRP-2

GH-releasing peptide / GH secretagogue

GHSR1aGhrelinGH SecretagogueAppetite
Rebuild

Glutathione

Endogenous antioxidant tripeptide

GSHRedoxAntioxidantOxidative Stress
Metabolic

HCG

Glycoprotein hormone

LHCGRReproductive AxisGonadalEndocrine
Reference

IGF-1 LR3

IGF-1 receptor agonist (engineered analogue)

IGF1RGrowth FactorPI3K/AKTRAS/MAPK
Peak

Ipamorelin

GH secretagogue

GHSR1aGH SecretagogueGhrelin PathwayGH
Enhance

Kisspeptin-10

Kisspeptin fragment

KISS1RGnRHLHFSH
Rebuild

KPV

α-MSH-derived tripeptide

KPVα-MSH FragmentInflammationIL-1-associated
Enhance

Melanotan I

α-MSH analogue

MC1RMelanocortinPigmentationα-MSH Analogue
Enhance

Melanotan II

Cyclic melanocortin agonist

MelanocortinMC ReceptorsPigmentationCyclic Peptide
Metabolic

MOTS-c

Mitochondrial-derived peptide

MitochondrialAMPK-associatedMetabolicExercise Biology
Metabolic

NAD+

Cellular redox cofactor

NAD+RedoxCellular EnergySirtuins
Enhance

PT-141

Cyclic melanocortin receptor agonist

MelanocortinMC4R-associatedCNSSexual Response
Metabolic

Retatrutide

Triple receptor agonist

GLP-1RGIPRGCGRIncretin
Reference

rHGH (Somatropin)

Growth hormone receptor agonist

GHRIGF-1Growth HormonePituitary-independent
Neuro

Selank

Synthetic tuftsin analogue

Tuftsin AnalogueCNSStress ResearchNeurotransmitter Research
Metabolic

Semaglutide

GLP-1 receptor agonist

GLP-1RIncretinMetabolicGlucose
Neuro

Semax

Synthetic ACTH-fragment analogue

ACTH FragmentNeurotrophinBDNF-associatedCNS
Peak

Sermorelin

GHRH fragment analogue

GHRHRGHRH(1-29)PituitaryGH
Rebuild

SS-31

Mitochondria-targeting tetrapeptide

MitochondriaCardiolipinInner Mitochondrial MembraneBioenergetics
Peak

Tesamorelin

Stabilised GHRH analogue

GHRHRGHIGF-1Pituitary
Rebuild

Thymosin Alpha-1

Thymic peptide

ImmuneT CellsTLR-associatedInnate Immunity
Rebuild

Thymosin Beta-4 (TB-4)

Thymosin Beta-4

Thymosin Beta-4Actin BiologyCell MigrationRepair Research
Metabolic

Tirzepatide

Dual incretin receptor agonist

GIPRGLP-1RDual AgonistIncretin

Simplified for general understanding — see this compound's "How does it work?" section for the full research-level description.